Curve Biosciences, Inc. — Form D

Curve Biosciences, Inc. of MOUNTAIN VIEW, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-13. The offering totals $20.0M, of which $17.7M was reported sold. Industry: Other.

Offering

• Filed: 2024-05-13
• Form: D
• Accession: 0002023059-24-000001
• Industry: Other
• Exemptions: 06b
• Total offering: $20.0M
• Amount sold: $17.7M
• Remaining: $2.3M
• Minimum investment: $1
• Investors: 64
• Date of first sale: 2024-05-01
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-513090

Issuer

• Name: Curve Biosciences, Inc.
• CIK: 0002023059
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2021
• Address: 319 N. BERNARDO AVENUE, MOUNTAIN VIEW, CA, 94043
• Phone: 214-680-9460

Officers, directors & promoters (7)

More

• CIK 2023059 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search